Osteopore (ASX:OSX) secured an exclusive two-year agreement with Peakmed for its craniofacial implant products in Thailand, according to a Tuesday filing with the Australian bourse.
Peakmed specializes in the distribution of surgical instruments and implants across craniomaxillofacial applications and has a distribution network of 70 hospitals across Thailand.
Osteopore's neurosurgical implants are focused on treating a range of brain surgeries where bone tissue is removed, such as burr hole and craniotomy procedures.
Its shares fell 6% on market close.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.